Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298-->Asp polymorphism) to the presence, extent, and severity of coronary artery disease
- PMID: 12010932
- PMCID: PMC1767141
- DOI: 10.1136/heart.87.6.525
Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298-->Asp polymorphism) to the presence, extent, and severity of coronary artery disease
Abstract
Background: Genetic variants of endothelial nitric oxide synthase (eNOS) could influence individual susceptibility to coronary artery disease.
Objective: To assess whether Glu298-->Asp polymorphism of the eNOS gene is associated with the occurrence and severity of angiographically defined coronary artery disease in the Italian population.
Methods: Polymerase chain reaction/restriction fragment length polymorphism analysis was done to detect the Glu298-->Asp variant of the eNOS gene in 201 patients with coronary artery disease and 114 controls. The severity of coronary artery disease was expressed by the number of affected vessels and by the Duke scoring system.
Results: The frequencies of the eNOS Glu/Glu, Glu/Asp, and Asp/Asp genotypes in the coronary artery disease group were significantly different from those of controls (45.3%, 38.8%, and 15.9% v 42.1%, 51.8%, and 6.1%, respectively; chi2 = 8.589, p = 0.0136). In comparison with subjects who had a Glu298 allele in the eNOS gene, the risk of coronary artery disease was increased among Asp/Asp carriers (odds ratio 2.9, 95% confidence interval 1.2 to 6.8, p = 0.01) and was independent of the other common risk factors (p = 0.04). There was a significant association between the eNOS Glu298-->Asp variant and both the number of stenosed vessels (mean (SEM), 2.3 (0.1) for Asp/Asp v 1.9 (0.1) and 1.8 (0.1) for Glu/Glu and Glu/Asp, respectively; p = 0.01) and the Duke score (56.1 (3.1) for Asp/Asp v 46.7 (2.0) and 46.1 (1.9) for Glu/Glu and Glu/Asp, respectively; p = 0.02).
Conclusions: Glu298-->Asp polymorphism of the eNOS gene appears to be associated with the presence, extent, and severity of angiographically assessed coronary artery disease.
Figures
Similar articles
-
Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease.Clin Chem. 2003 Mar;49(3):389-95. doi: 10.1373/49.3.389. Clin Chem. 2003. PMID: 12600950
-
[Association of endothelial nitric oxide synthase gene polymorphism with level of uric acid in serum for acute coronary syndrome].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Nov;19(11):652-6. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007. PMID: 17996131 Chinese.
-
Lack of association between Glu(298) asp polymorphism of endothelial nitric oxide synthase (eNOS) gene and coronary artery disease in Tamilian population.Indian Heart J. 2008 May-Jun;60(3):223-7. Indian Heart J. 2008. PMID: 19240311
-
Endothelial nitric oxide synthase polymorphisms and hypertension.Curr Hypertens Rep. 2003 Feb;5(1):19-25. doi: 10.1007/s11906-003-0006-0. Curr Hypertens Rep. 2003. PMID: 12530931 Review.
-
Cigarette smoking, DNA variants in endothelial nitric oxide synthase gene and vascular disease.Contrib Nephrol. 2000;130:53-67. doi: 10.1159/000060042. Contrib Nephrol. 2000. PMID: 10892551 Review. No abstract available.
Cited by
-
The Endothelial Nitric Oxide Synthase Gene T-786C Polymorphism Increases Myocardial Infarction Risk: A Meta-Analysis.Med Sci Monit. 2017 Feb 11;23:759-766. doi: 10.12659/msm.899905. Med Sci Monit. 2017. PMID: 28188309 Free PMC article.
-
Association of endothelial nitric oxide synthase gene polymorphisms with classical risk factors in development of premature coronary artery disease.Mol Biol Rep. 2013 Apr;40(4):3065-71. doi: 10.1007/s11033-012-2380-7. Epub 2012 Dec 27. Mol Biol Rep. 2013. PMID: 23269619
-
The 894G > T (Glu298Asp) variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline.Neuromolecular Med. 2011 Sep;13(3):167-74. doi: 10.1007/s12017-011-8148-8. Epub 2011 May 24. Neuromolecular Med. 2011. PMID: 21607713
-
Lack of association between Glu298Asp polymorphism and coronary artery disease in North Indians.Mol Biol Rep. 2012 May;39(5):5995-6000. doi: 10.1007/s11033-011-1412-z. Epub 2011 Dec 30. Mol Biol Rep. 2012. PMID: 22207178
-
Endothelial nitric oxide synthase Glu 298 Asp (G894T) and Apolipoprotein E gene polymorphism as possible risk factors for coronary heart disease among Egyptians.Egypt Heart J. 2018 Dec;70(4):393-401. doi: 10.1016/j.ehj.2018.08.001. Epub 2018 Sep 1. Egypt Heart J. 2018. PMID: 30591762 Free PMC article.
References
-
- Gotto AM. Interactions of the major risk factors for coronary heart disease. Am J Med 1986;80(suppl 2A):48–55. - PubMed
-
- Kannel WB. Clinical misconceptions dispelled by epidemiological research. Circulation 1995;92:3350–60. - PubMed
-
- Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factors categories. Circulation 1998;97:1837–47. - PubMed
-
- Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041–6. - PubMed
-
- Boerwinkle E, Ellsworth DL, Hallman DM, et al. Genetic analysis of atherosclerosis: a research paradigm for the common diseases. Hum Mol Genet 1996;5:1405–10. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical